Latest Tax Refunds News

Page 11 of 23
Agrimin Limited has ceased capital allocation to its Mackay Potash Project following a strategic review, while advancing exploration efforts in the promising West Arunta region.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Zelira Therapeutics has raised nearly US$33 million to fund clinical trials for its HOPE 1 cannabinoid-based medicine targeting autism, while also benefiting from a $1.07 million R&D tax refund.
Ada Torres
Ada Torres
29 Jan 2026
Li-S Energy has made significant strides in Q4 2025, securing a major government grant, forging key defence partnerships, and commissioning Australia’s first lithium foil production line.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Cleo Diagnostics has broadened its U.S. market opportunity to around 2 million women annually and is on track to complete its pivotal clinical trial early this year, supported by a $5 million capital raise and regulatory progress.
Ada Torres
Ada Torres
29 Jan 2026
Vitasora Health Limited reported a significant 22% increase in daily clinical billing productivity for the December 2025 quarter, alongside a 17% rise in operating revenue. With new CMS reimbursement policies now in effect, the company anticipates a further 10–20% revenue uplift in 2026.
Ada Torres
Ada Torres
29 Jan 2026
SenSen Networks has reported record cash receipts for the first half of FY26, driven by strong sales momentum in North America and Australia, alongside innovative product deployments.
Sophie Babbage
Sophie Babbage
28 Jan 2026
Alliance Nickel reported a $769,000 placement and a $422,000 R&D tax refund while progressing its NiWest Nickel-Cobalt Project, despite renegotiating its Stellantis offtake agreement due to market shifts.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Everest Metals has begun mining at its Mt Dimer Taipan Gold Project and reported strong drilling results at its Mt Edon Critical Minerals Project, advancing its position in gold and strategic minerals.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Elixir Energy has commenced drilling at the Lorelle-3 appraisal well in Queensland’s Taroom Trough, targeting significant gas resources with plans for advanced testing by mid-2026.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.
Ada Torres
Ada Torres
23 Jan 2026
Hazer Group advances its methane pyrolysis technology commercialization with a landmark alliance deal, extended partnerships, and a strengthened cash position, positioning itself at the forefront of low-carbon hydrogen and steelmaking solutions.
Maxwell Dee
Maxwell Dee
22 Jan 2026
BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.
Ada Torres
Ada Torres
21 Jan 2026

Browse the archive

Full archive